Literature DB >> 23065341

HDL and cardiovascular risk: time to call the plumber?

Bernd Hewing, Kathryn J Moore, Edward A Fisher.   

Abstract

Entities:  

Year:  2012        PMID： 23065341      PMCID： PMC3617479          DOI： 10.1161/CIRCRESAHA.112.280958

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  38 in total

Review 1.  Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance.

Authors:  J C Fruchart; G Ailhaud
Journal:  Clin Chem       Date:  1992-06       Impact factor: 8.327

2.  ApoA-I induction as a potential cardioprotective strategy: rationale for the SUSTAIN and ASSURE studies.

Authors:  Stephen J Nicholls; Allan Gordon; Jan Johannson; Christie M Ballantyne; Philip J Barter; H Bryan Brewer; John J P Kastelein; Norman C Wong; Marilyn R N Borgman; Steven E Nissen
Journal:  Cardiovasc Drugs Ther       Date:  2012-04       Impact factor: 3.727

3.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

4.  Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels.

Authors:  K F Kozarsky; M H Donahee; A Rigotti; S N Iqbal; E R Edelman; M Krieger
Journal:  Nature       Date:  1997-05-22       Impact factor: 49.962

5.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

6.  High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization.

Authors:  P K Shah; J Yano; O Reyes; K Y Chyu; S Kaul; C L Bisgaier; S Drake; B Cercek
Journal:  Circulation       Date:  2001-06-26       Impact factor: 29.690

7.  Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.

Authors:  Jean-Claude Tardif; Jean Grégoire; Philippe L L'Allier; Reda Ibrahim; Jacques Lespérance; Therese M Heinonen; Simon Kouz; Colin Berry; Russell Basser; Marc-André Lavoie; Marie-Claude Guertin; Josep Rodés-Cabau
Journal:  JAMA       Date:  2007-03-26       Impact factor: 56.272

8.  Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease.

Authors:  Christiane L Haase; Anne Tybjærg-Hansen; Peer Grande; Ruth Frikke-Schmidt
Journal:  J Clin Endocrinol Metab       Date:  2010-09-08       Impact factor: 5.958

9.  Dose-related effects of repeated ETC-216 (recombinant apolipoprotein A-I Milano/1-palmitoyl-2-oleoyl phosphatidylcholine complexes) administrations on rabbit lipid-rich soft plaques: in vivo assessment by intravascular ultrasound and magnetic resonance imaging.

Authors:  Cinzia Parolini; Marta Marchesi; Paolo Lorenzon; Mauro Castano; Elena Balconi; Luigi Miragoli; Linda Chaabane; Alberto Morisetti; Vito Lorusso; Bradley J Martin; Charles L Bisgaier; Brian Krause; Roger S Newton; Cesare R Sirtori; Giulia Chiesa
Journal:  J Am Coll Cardiol       Date:  2008-03-18       Impact factor: 24.094

10.  Mendelian randomisation, lipids, and cardiovascular disease.

Authors:  Seamus C Harrison; Michael V Holmes; Steve E Humphries
Journal:  Lancet       Date:  2012-05-17       Impact factor: 79.321
View more
  21 in total

1.  Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.

Authors:  Bernd Hewing; Saj Parathath; Tessa Barrett; Wing Ki Kellie Chung; Yaritzy M Astudillo; Tadateru Hamada; Bhama Ramkhelawon; Thomas C Tallant; Mohamed Shaif S Yusufishaq; Joseph A Didonato; Ying Huang; Jennifer Buffa; Stela Z Berisha; Jonathan D Smith; Stanley L Hazen; Edward A Fisher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-01-09       Impact factor: 8.311

Review 2.  LDL, HDL, VLDL, and CVD Prevention: Lessons from Genetics?

Authors:  Bernd Hewing; Ulf Landmesser
Journal:  Curr Cardiol Rep       Date:  2015-07       Impact factor: 2.931

3.  Mimetic peptides of human apoA-I helix 10 get together to lower lipids and ameliorate atherosclerosis: is the action in the gut?

Authors:  Geoffrey D Wool; Catherine A Reardon; Godfrey S Getz
Journal:  J Lipid Res       Date:  2014-08-01       Impact factor: 5.922

4.  Scavenger receptor BI and high-density lipoprotein regulate thymocyte apoptosis in sepsis.

Authors:  Ling Guo; Zhong Zheng; Junting Ai; Deborah A Howatt; Paul R Mittelstadt; Seth Thacker; Alan Daugherty; Jonathan D Ashwell; Alan T Remaley; Xiang-An Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-03-06       Impact factor: 8.311

Review 5.  High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studies.

Authors:  Jonathan E Feig; Bernd Hewing; Jonathan D Smith; Stanley L Hazen; Edward A Fisher
Journal:  Circ Res       Date:  2014-01-03       Impact factor: 17.367

6.  Increased plasma cholesterol esterification by LCAT reduces diet-induced atherosclerosis in SR-BI knockout mice.

Authors:  Seth G Thacker; Xavier Rousset; Safiya Esmail; Abdalrahman Zarzour; Xueting Jin; Heidi L Collins; Maureen Sampson; John Stonik; Stephen Demosky; Daniela A Malide; Lita Freeman; Boris L Vaisman; Howard S Kruth; Steven J Adelman; Alan T Remaley
Journal:  J Lipid Res       Date:  2015-05-11       Impact factor: 5.922

Review 7.  HDL and Reverse Cholesterol Transport.

Authors:  Mireille Ouimet; Tessa J Barrett; Edward A Fisher
Journal:  Circ Res       Date:  2019-05-10       Impact factor: 17.367

8.  Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity.

Authors:  Alan R Tall; Nan Wang; Andrew J Murphy; Samuel Funt; Darren Gorman
Journal:  Circ Res       Date:  2013-04-23       Impact factor: 17.367

Review 9.  High-density lipoprotein function, dysfunction, and reverse cholesterol transport.

Authors:  Edward A Fisher; Jonathan E Feig; Bernd Hewing; Stanley L Hazen; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12       Impact factor: 8.311

Review 10.  [Impact of lipid metabolism parameters on the development and progression of coronary artery disease : An update].

Authors:  D Sinning; D M Leistner; U Landmesser
Journal:  Herz       Date:  2016-06       Impact factor: 1.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.